Nexavar Dosing in Renal Cancer Patients in "Real-life" Setting
Status:
Completed
Trial end date:
2016-03-31
Target enrollment:
Participant gender:
Summary
This study is a registry of renal cancer patients treated with Nexavar. It aims to evaluate
the actual dosing of Nexavar in "real-life" setting vs. the prescribed dose.